BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Divis Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532488
ISIN Demat
INE361B01024
Book Value (Rs)
629.4942217
NSE Symbol
DIVISLAB
Divident Yield %
0.3
Market Cap
(Rs In Cr.)
264,141
P/E (TTM)
88.17
EPS (TTM)
112.85
Face Value
(Rs)
2
Back
Divi's Laboratories consolidated net profit rises 65.50% in the June 2026 quarter
01-Aug-26   Hrs IST

Net profit of Divi's Laboratories rose 65.50% to Rs 902.00 crore in the quarter ended June 2026 as against Rs 545.00 crore during the previous quarter ended June 2025. Sales rose 27.80% to Rs 3080.00 crore in the quarter ended June 2026 as against Rs 2410.00 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales3080.002410.00 28
OPM %40.7530.25 -
PBDT1313.00845.00 55
PBT1180.00733.00 61
NP902.00545.00 66

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)